Canadian Pharma Company To Acquire Israeli Medical Cannabis Firm Therapix Biosciences
Therapix shareholders will be receiving $48 million in stock in a transaction expected to close early next year.
October 24, 2018
Canadian Cannabis Cultivator To Launch Clinical Study In Israel Via HMO
The Ontario-based producer said it was starting a collaborative research program with the technology transfer office of Israel's largest healthcare provider Clalit.
August 19, 2018